U.S. Consumer Finance Stock News

Kenvue (NYSE:KVUE) is progressing toward a pending US$40b acquisition by Kimberly-Clark. Shareholders and major U.S. antitrust authorities have given their approvals. The company is pursuing its 2026 Restructuring Initiative alongside the transaction process. Kenvue, a consumer health company, is at the center of one of the larger proposed deals in its sector, with a pending US$40b acquisition by Kimberly-Clark. With shareholder and key U.S. antitrust approvals already in place, investors...

Wondering whether Snowflake's current share price reflects its true worth or if the market is mispricing the stock? This article walks through the numbers so you can judge the valuation for yourself. Snowflake closed at US$153.72 recently, with a 12.6% return over the last 7 days and 3.0% over 30 days, set against a year-to-date return of a 29.1% decline and an 11.6% decline over the past year. These mixed returns sit alongside ongoing investor interest in data infrastructure and cloud...

In early May 2026, Guidewire Software participated in a broad software sector rally, with its move largely tied to stronger industry-wide investor interest rather than new company-specific announcements. At the same time, CEO Michael Rosenbaum’s continued share sales, alongside a year of only insider selling activity, raise questions about how leadership’s trading behavior aligns with market optimism around Guidewire’s positioning. We’ll now examine how Guidewire’s sector-driven momentum,...

In early May 2026, General Mills promoted longtime executive Dana McNabb to Chief Operating Officer and board member, expanding her remit to all global operating segments and key functions including supply chain, innovation, and digital. This leadership shift, paired with refreshed incentives for top executives, highlights General Mills’ push to tighten execution, accelerate innovation, and reinforce long-term management continuity. We’ll now examine how McNabb’s expanded operational control...

In late April 2026, Floor & Decor Holdings, Inc. outlined fiscal 2026 earnings guidance, reported softer first‑quarter results, announced plans to open 20 new warehouse stores, and authorized a US$400 million share repurchase program without an expiration date. Taken together, these updates highlight a company balancing continued store expansion with shareholder returns, while signaling its view of long‑term demand for hard‑surface flooring in the United States. Next, we’ll examine how the...

Wondering whether HubSpot at around US$243.72 is a bargain or a value trap? This article walks through what the current share price might be implying about the stock's worth. The stock has moved 9.9% over the last 7 days and 7.1% over the last 30 days, yet the return over the last year sits at a 63.1% decline and the year to date return is a 36.2% decline. Recent coverage has focused on HubSpot's position in marketing and sales software and how investors are reassessing growth stocks with...

If you are wondering whether Domino's Pizza at around US$332 a share represents good value or is priced for perfection, this breakdown will help you judge whether the stock still fits your expectations. The stock has seen a 2.0% slip over the last week, a 9.7% decline over the last month, a 21.8% drop year to date and a 29.1% fall over the past year, which may change how you think about both risk and opportunity here. These moves sit against a backdrop in which investors are reassessing long...

ADTRAN Holdings earnings and guidance move into focus ADTRAN Holdings (ADTN) has come under closer scrutiny after first quarter results showed higher revenue and a smaller net loss, alongside fresh second quarter revenue guidance that framed expectations for the rest of 2026. See our latest analysis for ADTRAN Holdings. Despite the latest quarterly update, the stock’s 1-day share price return of 7.38% and 7-day share price return of 17.75% were weak. However, the 90-day share price return of...

Wondering if Adecoagro's recent share price puts it at a bargain or already reflects its strengths? This article breaks down what the current valuation is really telling you. The stock last closed at US$13.37, with a 72.3% return year to date and a 59.0% return over the past year. This is set against shorter term pullbacks of 5.1% over 7 days and 11.0% over 30 days that may signal shifting sentiment around risk and reward. Recent news around global food supply resilience, agricultural input...

Q1 earnings surprise puts focus on NRG Energy stock NRG Energy (NRG) is back in the spotlight after Q1 2026 results showed revenue above expectations but earnings per share below forecasts, alongside reaffirmed full year guidance and an active build out of new Texas gas capacity. See our latest analysis for NRG Energy. The share price has retreated recently, with a 1 day share price return of a 5.83% decline and a year to date share price return of a 14.62% decline. This comes even though the...

Hawaiian Electric Industries (HE) has reported fourth quarter FY 2025 revenue of US$805.8 million and basic EPS of US$0.23, rounding out a trailing twelve month EPS of US$0.71 on revenue of about US$3.1 billion. The company has seen quarterly revenue move from US$799.2 million and EPS of US$0.17 in Q4 2024 to US$805.8 million and EPS of US$0.23 in Q4 2025. Over the same period, the trailing twelve month line has shifted from revenue of US$3.2 billion and EPS of a US$10.42 loss in Q4 2024 to...

XPeng (XPEV) is back in focus after reporting April 2026 deliveries of 31,011 vehicles, a 13% month on month rise. The company also highlighted ongoing work on physical AI projects and global expansion plans. See our latest analysis for XPeng. Despite the recent April delivery update and ongoing work on physical AI and global expansion, XPeng’s short term share price return has been weak, with a 30 day share price return of a 9.7% decline and a year to date share price return of a 23.9%...

If you are wondering whether MaxLinear's recent share price move has left the stock looking expensive or still potentially interesting, the valuation story is where your attention should be. The stock last closed at US$82.37, with returns of 16.4% over 7 days, 347.4% over 30 days, 345.0% year to date and a very large 1 year gain that is more than 6x. These moves sit against a backdrop of ongoing interest in semiconductor stocks, with investors watching closely for updates on demand for...

Alamar Biosciences (NasdaqGS:ALMR) doubled its revenue in Q1 2026. The company launched two new products aimed at neurodegenerative disease research. Alamar completed an IPO in 2026 to support its next phase of growth. Alamar Biosciences operates in the life sciences tools and diagnostics space, where demand for more precise protein and biomarker measurement has been a key theme for researchers and drug developers. The new products focused on neurodegenerative disease research sit in an...

Why the upcoming TN-401 data matters for Tenaya Therapeutics stock Tenaya Therapeutics (TNYA) is drawing attention as investors look ahead to new clinical safety and efficacy data for TN-401, its gene therapy for PKP2-associated arrhythmogenic right ventricular cardiomyopathy, at the ASGCT 2026 meeting. This late breaking oral presentation, together with additional abstracts on Tenaya’s gene therapy and gene editing programs, gives you fresh information to evaluate the company’s pipeline...

Brixmor Property Group Inc. recently reported first-quarter 2026 results showing year-on-year growth in revenue to US$354.82 million and net income to US$127.75 million, while also updating full-year guidance to net income of US$355 million to US$365 million and diluted EPS of US$1.16 to US$1.19. Alongside the earnings update, the board affirmed a quarterly dividend of US$0.3075 per share and highlighted that 2026 uncollectible revenues are expected to remain contained at 75 to 100 basis...

Sarepta Therapeutics (NasdaqGS:SRPT) is progressing its small interfering RNA (siRNA) candidates SRP-1001 and SRP-1003, with early data viewed as encouraging. The company is seeking to transition AMONDYS 45 and VYONDYS from accelerated to traditional FDA approvals through recent regulatory submissions. These updates come as Sarepta refines its commercial focus beyond gene therapy Elevidys, which continues to face regulatory and commercial complexity. Sarepta Therapeutics focuses on rare...

Why Gold.com (GOLD) is back on investors’ radar after record Q3 results Gold.com (GOLD) is in focus after reporting record fiscal third quarter revenue of US$10.35b, a swing to net income of US$59.49m, and affirming a quarterly dividend alongside new digital asset partnerships. See our latest analysis for Gold.com. At a share price of US$43.51, Gold.com has seen a 25.14% year to date share price return and a very large 1 year total shareholder return of 114.36%. However, the 90 day share...

Wendy's (NasdaqGS:WEN) has announced a major franchise agreement to open up to 1,000 restaurants in China over the next decade. The expansion is part of its "Project Fresh" turnaround plan and is intended to offset weaker U.S. same-restaurant sales. The deal marks a shift in focus toward international markets as the company looks for new long term growth drivers. Wendy's, trading at around $6.95, has seen extended share price pressure, with the stock down 14.9% year to date and 39.1% over...

If you are wondering whether Chevron at around US$182.50 is offering fair value or if you are paying up for the story, this article walks through what the numbers are actually saying about the stock. The share price has pulled back recently, with a 5.6% decline over the last 7 days and a 9.4% decline over the last 30 days, while still showing returns of 17.1% year to date and 39.2% over 1 year. Recent headlines around Chevron have focused on broad energy sector sentiment and ongoing interest...

Natera (NasdaqGS:NTRA) raised its full-year 2026 revenue and gross margin guidance after reporting record test volumes. The company cited accelerating growth in both women's health and oncology segments as key drivers. Natera also outlined plans to commercially launch its Signatera MRD test in Japan, aiming to extend its international reach. Natera enters this update with its stock at $219.82 and a 1 year return of 35.2%, and a 3 year return that is a very large multiple of its earlier...

CoStar Group (NasdaqGS:CSGP) is set to be removed from the Nasdaq-100 Index. The change affects the stock's role in one of the most followed US equity benchmarks. Index adjustments can influence passive fund holdings and trading activity in the shares. For investors watching CoStar Group, the index removal intersects with a share price that most recently closed at $34.98. The stock has recorded a 1.1% return over the past week, alongside longer term declines of 11.4% over 30 days, 46.7%...

Wondering if AMETEK at around US$234.73 is offering fair value or if you might be paying up for quality? This article breaks down what the current price could mean for you. The stock has been relatively flat over the last 7 days with a 0.3% decline, but sits on gains of 7.8% over 30 days, 12.2% year to date and 37.7% over 1 year. This naturally raises questions about how much of the story is already priced in. Recent coverage has focused on AMETEK's position in the capital goods space and...

Why Brown & Brown (BRO) is Back on Investors’ Radar Brown & Brown (BRO) has drawn fresh attention after recent trading left the stock about 25% lower year to date, with the share price at US$58.05 and a market value near US$19.2b. See our latest analysis for Brown & Brown. The 1-day share price return of 2.63% sits against a 30-day share price return of 12.54% and a year to date share price return of 25.21%. The 1-year total shareholder return of 47.57% contrasts with a 3-year total...